mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.007 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |